Friends
The whole issue of late onset resistance to ibrutinib and other TKIs is a growing area of concern and research.
I will posting more on it in my blog ( bkoffman.blogspot.com ), but Dr. Furman gives us a nice starting perspective.
Stay strong
Brian
Admin: Links now working (HU will not cope with any characters adjacent to the end of the link and it is best to have spaces before and after links.)